Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC.ACHV · Entity 5072 | Principal Accounting Officer | January 28, 2025 | January 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACHIEVE LIFE SCIENCES, INC.
Report date January 28, 2025 · Filed January 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.36 · Expires 2036-01-28 | Direct | 70,300 |
Reported balance
After 2026-01-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-28 · Grant · Acquired 70,300 · Balance 70,300 F1: The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2026 Filed Jan 30, 2026 21:05 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 70,300 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001193125-26-031761 · ownership.xml · derivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,300 Underlying: Common Stock · 70,300 shares Expires 2036-01-28 F1 · derivative.exercise_date: The option will vest as to 1/4 of the total award on the first anniversary of January 28, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:59 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 9,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113592 · ownership.xml · derivative · entry 4 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,400 Underlying: Common Stock · 9,600 shares Expires 2035-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F8 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:59 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 24,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113592 · ownership.xml · derivative · entry 3 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,500 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F6 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:59 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | SaleCommon Stock | 14,070 | $2.77 | $38,973.90 |
DisclosureSEC source: 0000950170-25-113592 · ownership.xml · nonDerivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,694 F2 · shares: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:59 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 34,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113592 · ownership.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:54 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 48,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011164 · ownership.xml · derivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Underlying: Common Stock · 48,000 shares Expires 2035-01-28 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:11 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantCommon Stock | 2,857 | $3.67 | $10,485.19 |
DisclosureSEC source: 0000950170-24-099091 · ownership.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,664 F1 · kind: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046984 · ownership.xml · derivative · entry 3 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,625 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 2,250 | $4.51 | $10,147.50 |
DisclosureSEC source: 0000950170-24-046984 · ownership.xml · nonDerivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,807 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046984 · ownership.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 00:05 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 10,500 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-24-002198 · doc4.xml · derivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires 2034-01-22 F3 · derivative.exercise_date: The options vest one-third on the first anniversary of January 22, 2024 and thereafter in monthly installments over 24 months. Read SEC document |
| January 22, 2024 Filed Jan 25, 2024 00:05 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 24,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002198 · doc4.xml · derivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires 2028-01-22 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met. The PRSUs will lapse in full if achievement of at least one of the milestones is not met. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026322 · doc4.xml · derivative · entry 3 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires 2025-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 669 | $8.29 | $5,546.01 |
DisclosureSEC source: 0001209191-23-026322 · doc4.xml · nonDerivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,432 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026322 · doc4.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 20:17 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025384 · doc4.xml · derivative · entry 3 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,625 Underlying: Common Stock · 5,625 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 20:17 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 3,010 | $6.80 | $20,468.00 |
DisclosureSEC source: 0001209191-23-025384 · doc4.xml · nonDerivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,851 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 20:17 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025384 · doc4.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 21:49 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $4.90 | $0.00 |
DisclosureSEC source: 0001209191-23-005291 · doc4.xml · derivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-01-25 F3 · derivative.exercise_date: The options vest one-third on the first anniversary of January 25, 2023 and thereafter in monthly installments over 24 months. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 21:49 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-005291 · doc4.xml · derivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2025-12-31 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuers common stock that may ultimately vest range from 0% to 100% of the number of PRSUs initially granted, subject to certain milestones being met during the measurement period that begins on January 3, 2023 and ends on December 31, 2025. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:38 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 266 | $4.37 | $1,162.42 |
DisclosureSEC source: 0001209191-22-046644 · doc4.xml · nonDerivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,236 F2 · shares: Represents shares of common stock that have been withheld by the Issuer to satisfy the tax liability in connection with the purchase of shares under the ESPP. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:38 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantCommon Stock | 2,827 | $4.37 | $12,353.99 |
DisclosureSEC source: 0001209191-22-046644 · doc4.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,502 F1 · kind: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 20:50 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026289 · doc4.xml · derivative · entry 3 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires 2025-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 20:50 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 669 | $7.43 | $4,970.67 |
DisclosureSEC source: 0001209191-22-026289 · doc4.xml · nonDerivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 20:50 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026289 · doc4.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:38 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001209191-22-001728 · doc4.xml · derivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2032-01-03 F3 · derivative.exercise_date: The options vest one-third on the first anniversary of January 3, 2022 and thereafter in monthly installments over 24 months. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:38 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001728 · doc4.xml · derivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2026-01-03 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The PRSUs will lapse in full if achievement of such milestone is not met. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:07 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052568 · doc4.xml · derivative · entry 3 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 1, 2017 and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:07 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 6 | $6.81 | $40.86 |
DisclosureSEC source: 0001209191-21-052568 · doc4.xml · nonDerivative · entry 2 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:07 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052568 · doc4.xml · nonDerivative · entry 1 Wan Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:35 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001209191-21-005889 · doc4.xml · derivative · entry 2 Wann Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-01-26 F3 · derivative.exercise_date: The options vest 25% on the first anniversary of January 26, 2021 and thereafter in monthly installments over 36 months. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:35 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-005889 · doc4.xml · derivative · entry 1 Wann Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-01-26 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The PRSUs will lapse in full if achievement of such milestone is not met. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:51 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $10.36 | $0.00 |
DisclosureSEC source: 0001209191-20-059147 · doc4.xml · derivative · entry 1 Wann Jerry · CIK 0001828041 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-11-16 F1 · derivative.exercise_date: Pursuant to the terms of the options 50% of the total shares underlying the option vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The options will lapse in full if achievement of such milestone is not met. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.